This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Chiauranib
DrugBank Accession Number
DB16124
Background

Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 435.483
Monoisotopic: 435.158291548
Chemical Formula
C27H21N3O3
Synonyms
Not Available
External IDs
  • CS-2164
  • CS2164

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
F40IRN5981
CAS number
1256349-48-0
InChI Key
BRKWREZNORONDU-UHFFFAOYSA-N
InChI
InChI=1S/C27H21N3O3/c1-32-18-9-12-22-25(16-18)29-14-13-26(22)33-19-10-11-20-17(15-19)5-4-6-21(20)27(31)30-24-8-3-2-7-23(24)28/h2-16H,28H2,1H3,(H,30,31)
IUPAC Name
N-(2-aminophenyl)-6-[(7-methoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide
SMILES
COC1=CC=C2C(OC3=CC4=CC=CC(C(=O)NC5=CC=CC=C5N)=C4C=C3)=CC=NC2=C1

References

General References
Not Available
ChemSpider
81367270

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3RecruitingPreventionChiauranib / Ovarian Cancer / Paclitaxel / Relapsed or Refractory1
3RecruitingTreatmentSmall Cell Lung Cancer (SCLC)1
2CompletedTreatmentOvarian Cancer1
2RecruitingTreatmentTriple Negative Breast Cancer1
1CompletedTreatmentSolid Tumors1
1RecruitingTreatmentHealthy Subjects (HS)1
1RecruitingTreatmentSmall Cell Lung Cancer (SCLC)1
1TerminatedTreatmentNon-Hodgkin's Lymphoma (NHL)1
1, 2CompletedTreatmentHepatocellular Carcinoma1
1, 2CompletedTreatmentNon-Hodgkin's Lymphoma (NHL)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000363 mg/mLALOGPS
logP4.82ALOGPS
logP4.73ChemAxon
logS-6.1ALOGPS
pKa (Strongest Acidic)15.47ChemAxon
pKa (Strongest Basic)5.69ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area86.47 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity129.37 m3·mol-1ChemAxon
Polarizability46.52 Å3ChemAxon
Number of Rings5ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at December 15, 2020 18:13 / Updated at December 20, 2020 03:37